| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/13/2002 | CA2431151A1 Heterocyclic ether substituted imidazoquinolines |
| 06/13/2002 | CA2431013A1 Methods and compositions for highly efficient production of heterologous proteins in yeast |
| 06/13/2002 | CA2430993A1 G-protein coupled receptors |
| 06/13/2002 | CA2430893A1 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 06/13/2002 | CA2430844A1 Aryl ether substituted imidazoquinolines |
| 06/13/2002 | CA2430713A1 Process for selecting anti-angiogenesis antibody fragments, anti-angiogenesis antibody fragments thus obtained and their use |
| 06/13/2002 | CA2430712A1 Schizophrenia-related voltage-gated ion channel gene and protein |
| 06/13/2002 | CA2430558A1 Proteins and nucleic acids encoding same |
| 06/13/2002 | CA2430536A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/13/2002 | CA2430524A1 Human transporter proteins, nucleic acid molecules encoding them,and uses thereof |
| 06/13/2002 | CA2430379A1 Endogenous retroviruses up-regulated in prostate cancer |
| 06/13/2002 | CA2430206A1 Screening method for identifying compounds that selectively induce interferon alpha |
| 06/13/2002 | CA2430191A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/13/2002 | CA2429959A1 Adipocyte complement related protein zacrp3x2 |
| 06/13/2002 | CA2429641A1 Kinases and phosphatases |
| 06/13/2002 | CA2428390A1 Enzymes |
| 06/13/2002 | CA2428382A1 Intestinal proteins |
| 06/13/2002 | CA2428208A1 Lipid-associated molecules |
| 06/13/2002 | CA2427820A1 Method of producing biospecific molecules by protein trans-splicing |
| 06/13/2002 | CA2427615A1 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 06/13/2002 | CA2425396A1 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) |
| 06/12/2002 | EP1213350A2 Method for preparing polypeptide variants by in vivo recombination |
| 06/12/2002 | EP1213298A1 Antibiotics GE 23077, pharmaceutically acceptable salts and compositions, and use thereof |
| 06/12/2002 | EP1213297A1 Novel tachykinin peptides, precursor peptides thereof and genes encoding the same |
| 06/12/2002 | EP1213030A1 Method for producing biologicals in protein-free culture |
| 06/12/2002 | EP1212620A1 Essential genes and assays relating thereto |
| 06/12/2002 | EP1212450A2 Method for increasing the yield of recombinant proteins in microbial fermentation processes |
| 06/12/2002 | EP1212431A2 Phosphomevalonate kinase (pmk) gene (erg8) from candida albicans |
| 06/12/2002 | EP1212419A2 Polycyclic aromatic hydrocarbon induced molecules |
| 06/12/2002 | EP1212418A2 p193 PROTEINS AND NUCLEIC ACIDS, AND USES THEREOF |
| 06/12/2002 | EP1212417A2 Interleukin-1-receptor associated kinase-3 (irak3) |
| 06/12/2002 | EP1212415A1 Pgrp-l polynucleotides, polypeptides, and antibodies |
| 06/12/2002 | EP1212410A2 Dna encoding the human serine protease eos |
| 06/12/2002 | EP1212407A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 06/12/2002 | EP1212362A2 Card proteins involved in cell death regulation |
| 06/12/2002 | EP1212358A2 Synthetic papillomavirus genes optimized for expression in human cells |
| 06/12/2002 | EP1212349A1 Recombinant subunit vaccine |
| 06/12/2002 | EP1212344A1 B7-like polynucleotides, polypeptides, and antibodies |
| 06/12/2002 | EP1212343A1 52 human secreted proteins |
| 06/12/2002 | EP1212342A2 18 human secreted proteins |
| 06/12/2002 | EP1212340A1 29 human cancer associated proteins |
| 06/12/2002 | EP1212298A1 Isolation of natural l-beta-3-indolylalanine and enrichment of natural aliphatic amino acid mixtures with natural l-beta-3-indolylalanine |
| 06/12/2002 | EP1212082A1 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies |
| 06/12/2002 | EP1212074A1 Hybrid peptides modulate the immune response |
| 06/12/2002 | EP1212043A2 Composition to be administered through mucous membrane |
| 06/12/2002 | EP1084227A4 Compositions and methods for use in affecting hematopoietic stem cell populations in mammals |
| 06/12/2002 | EP0802800B1 Biocompatible immunoisolatory capsules containing genetically altered cells for the delivery of biologically active molecules |
| 06/12/2002 | EP0749325B1 Bispecific molecules having clinical utilities |
| 06/12/2002 | EP0749317B1 Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
| 06/12/2002 | EP0741576B1 Co-administration of interleukin-3 mutants with colony stimulating factors |
| 06/12/2002 | EP0722452B1 Nf-at polypeptides and polynucleotides |
| 06/12/2002 | EP0574395B1 Cytokine immunoconjugates |
| 06/12/2002 | EP0433372B1 Oral immunization by transgenic plants |
| 06/12/2002 | CN1353761A Preparation of biologically active molecules |
| 06/12/2002 | CN1353757A Microbiological production method for 2-L-aspartyl-L-phenylalanine |
| 06/12/2002 | CN1353755A Method of removing N-terminal alanine residues from polypeptides with aeromonas aminopeptidase |
| 06/12/2002 | CN1353754A Variants of TRAF2 which act as an inhibitor of TNF-alpha (TNF alpha) signaling pathway |
| 06/12/2002 | CN1353678A Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor |
| 06/11/2002 | US6403770 Antibodies to neutrokine-alpha |
| 06/11/2002 | US6403769 Fusion protein having nonantibody portion comprised of effector domain from growth factor or growth factor receptor joined to aminoterminal end of immunoglobulin g-derived sequence which lacks ch1 domain |
| 06/11/2002 | US6403559 C-kit ligand-based method for expanding peripheral blood cell levels |
| 06/11/2002 | US6403552 Ob receptor and methods for the diagnosis and treatment of body weight disorders |
| 06/11/2002 | US6403374 Long wavelength engineered fluorescent proteins |
| 06/11/2002 | US6403361 Enzymatic method for modification of recombinant polypeptides |
| 06/11/2002 | US6403360 Isolated nucleic acids |
| 06/11/2002 | US6403336 Dna segment encodes protective peptide-fused atriopeptin; microorganisms transformed with vectors; genetic engineering |
| 06/11/2002 | US6403335 Amino acid sequence; promotes survival of mesencephalic cells; nervous system and degenerative disorders; parkinson*s disease; genetic engineering |
| 06/11/2002 | US6403327 Diagnostic method using expression of MN/CA9 protein in ASCUS Pap smears |
| 06/11/2002 | US6403102 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 06/11/2002 | US6403101 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 06/11/2002 | US6403099 Conjugates formed from heat shock proteins and oligo-or polysaccharides |
| 06/11/2002 | US6403097 Deletion in the glycoprotein ge-gene |
| 06/11/2002 | US6403091 Produced by the hybridoma having atcc accession no. hb 10916. |
| 06/11/2002 | US6403087 Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of immunological disease |
| 06/11/2002 | US6403082 Administering polynucleotide |
| 06/11/2002 | US6403080 Methods of modulating an immune response to antigen, and cells for use in the method |
| 06/11/2002 | US6403079 Using polypeptide |
| 06/11/2002 | US6403077 Treatment regimes featuring an IL-10-containing chimeric polypeptide |
| 06/11/2002 | CA2169629C Human erythropoietin receptor fragment and antibodies thereto |
| 06/11/2002 | CA2124218C Cytotoxic drug therapy |
| 06/11/2002 | CA2095861C Structural proteins from artificial genes |
| 06/11/2002 | CA2088478C Cloning and expression of a rhoptry associated protein of p. falciparum |
| 06/11/2002 | CA2082390C Dna encoding human 5-ht1d receptors and uses thereof |
| 06/11/2002 | CA2061167C Process for the purification of a highly glycolsylated protein |
| 06/11/2002 | CA1341367C Enhanced production of proteins by cell culture |
| 06/06/2002 | WO2002044736A2 Diagnosis and treatment of epidermal or skin diseases |
| 06/06/2002 | WO2002044718A2 S.aureus protein staau r2, gene encoding it and uses thereof |
| 06/06/2002 | WO2002044406A2 Projection against mycobacterial infections |
| 06/06/2002 | WO2002044388A1 Production of heterologous polypeptides in yeast |
| 06/06/2002 | WO2002044379A2 Transforming growth factor-beta-related molecules and uses thereof |
| 06/06/2002 | WO2002044377A2 Obp1:a protein selectively expressed in osteoblasts |
| 06/06/2002 | WO2002044374A2 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 06/06/2002 | WO2002044373A2 Adipocyte complement related protein zacrp12 |
| 06/06/2002 | WO2002044371A1 Human protooncogene and protein encoded therein |
| 06/06/2002 | WO2002044370A1 Human cervical cancer 2 protooncogene and protein encoded therein |
| 06/06/2002 | WO2002044366A2 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |
| 06/06/2002 | WO2002044364A2 Polypeptides involved in immune response |
| 06/06/2002 | WO2002044355A2 Protozoan expression systems for lysosomal storage disease genes |
| 06/06/2002 | WO2002044336A2 Method of making a protein polymer and uses of the polymer |
| 06/06/2002 | WO2002044321A2 Rna interference mediating small rna molecules |